Biography and Research Information
OverviewAI-generated summary
Clyde Baily's research focuses on the application of risk stratification models to patients undergoing medical treatments. His most recent publication in 2023 examined the application of the R2-ISS risk stratification system for patients with multiple myeloma who received autologous stem cell transplants at the University of Arkansas for Medical Sciences (UAMS). Baily has collaborated with several researchers at UAMS on this and related work, including Guido Tricot, David E. Mery, Manit Munshi, and Maurizio Zangari, with whom he has co-authored publications. With a total of three publications and 13 citations, Baily has an h-index of 2. His work indicates recent activity in the field.
Metrics
- h-index: 2
- Publications: 3
- Citations: 13
Selected Publications
-
Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS (2023)
Collaboration Network
Top Collaborators
Wancheng Guo
Central South University (CN)
1 shared publication
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Anne Zhan
Little Rock School District (US)
1 shared publication
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
David E. Mery
University of Arkansas for Medical Sciences
1 shared publication
In database
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Manit Munshi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
O. Makhoul
University of Arkansas for Medical Sciences
1 shared publication
In database
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Maurizio Zangari
University of Arkansas for Medical Sciences
1 shared publication
In database
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Guido Tricot
University of Arkansas for Medical Sciences
1 shared publication
In database
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Hongling Peng
Second Xiangya Hospital of Central South University (CN)
1 shared publication
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
John D. Shaughnessy
University of Arkansas for Medical Sciences (US)
1 shared publication
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Similar Researchers
Based on overlapping research topics
O. Makhoul
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Frits Vanrhee
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Jaskirat S Sethi
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Bart Barlogie
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Kerri Hill
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
B Barlogie
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology